Boston University

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Boston University sits in the top decile of US sponsors by registered trial count (#161 of 15,742 sponsors by registered trial count).

185 total trials 23 currently recruiting 125 completed early-phase tilt top decile by trial count

Boston University: 185 sponsored US clinical trials, 23 recruiting.

Boston University sponsors 185 registered US clinical trials on ClinicalTrials.gov, 23 of them currently recruiting, and 125 completed. 12 of these trials are in Phase 3-4 (later-stage) and 35 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is HIV Infections, with 3 trials.

Top-decile sponsor footprint

Boston University ranks in the top decile of sponsors by registered trial count (#161 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

D 51/100

125 of 148 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (84.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

185 total, page 4 of 4

COMPLETED NA

Alcohol Self Administration Laboratory

NCT00398918

COMPLETED Phase 4

Effect of Testosterone in Men With Erectile Dysfunction

NCT00512707

COMPLETED Phase 2

The Effects of Zonisamide on Alcohol Dependence

NCT00406692

COMPLETED Phase 1

Acute and Residual Effects of Caffeinated Beer

NCT00515294

COMPLETED

Evaluating the Link Between Neighborhood Environments and Obesity Among African American Women

NCT00356707

COMPLETED Phase 2

Effects of Testosterone Replacement on Pain Sensitivity and Pain Perception

NCT00351819

COMPLETED Phase 1

Mycophenolate Mofetil in Systemic Sclerosis

NCT00433186

COMPLETED NA

Insertion of an Intrauterine Device (IUD) After Medical Abortion

NCT00621543

COMPLETED NA

Blood Pressure Lowering Effects of Grape Juice

NCT00302809

COMPLETED Phase 2

The Effect of Diflunisal on Familial Amyloidosis

NCT00294671

COMPLETED Phase 4

The Effects of Levetiracetam on Alcohol Dependent Subjects

NCT00325182

COMPLETED NA

Testing the Re-Engineered Hospital Discharge

NCT00252057

COMPLETED Phase 2

Efficacy of Mirtazapine in Depressed Cocaine Dependent Subjects

NCT00322309

COMPLETED Early Phase 1

Effects of Lipemia and Metformin on Endothelial Function

NCT01037660

TERMINATED NA

Effect of a Fibrate and a Statin on Endothelial Dysfunction

NCT00491400

TERMINATED Phase 2

Celebrex (Celecoxib) Treatment of Laryngeal Papilloma

NCT00592319

COMPLETED NA

Mifepristone and Mid-Trimester Termination of Pregnancy

NCT00382538

COMPLETED Phase 2

Effectiveness of Intensive Cognitive Behavioral Therapy in Treating Adolescent Panic Disorder and Agoraphobia

NCT00576719

COMPLETED NA

A Randomized Controlled Trial Testing The Effect Of A Multi-Nutrient Fortified Juice

NCT01909063

COMPLETED NA

Impact of Gum Infection on Heart Disease

NCT00093236

TERMINATED Phase 1

Clinical Utility of Endothelial Dysfunction in PAD

NCT00491751

COMPLETED Phase 2

Citalopram for Children With Autism and Repetitive Behavior (STAART Study 1)

NCT00086645

COMPLETED Phase 2

Residual Effects of Intoxication on Student Performance

NCT00183170

COMPLETED Phase 4

The Effects of Topiramate on Alcohol Use in Alcohol Dependent Subjects

NCT00329407

COMPLETED NA

Sulfasalazine and Endothelial Function

NCT00554203

COMPLETED Phase 1

Transcranial Magnetic Stimulation to Improve Speech in Aphasia

NCT00608582

COMPLETED Phase 1

Brief Cognitive-Behavioral Treatment for Victims of Mass Violence

NCT00495027

COMPLETED Phase 3

Shoe Inserts for Treating Osteoarthritis of the Knee

NCT00032240

COMPLETED Phase 1

Study of Oral Bexarotene in Combination With Photopheresis for Treatment of Cutaneous T-Cell Lymphoma

NCT00306969

COMPLETED NA

Training Improves Balance Control

NCT01547988

TERMINATED

Alcoholism: Emotion and Thinking

NCT00300638

COMPLETED Phase 2

Phase II Study of Arginine Butyrate With or Without Epoetin Alfa in Patients With Thalassemia Intermedia

NCT00006136

COMPLETED Phase 3

Fluoxetine vs EMDR to Treat Post-Traumatic Stress Disorder (PTSD)

NCT00000379

COMPLETED Phase 2

Effectiveness of Cognitive Behavioral Therapy With Panic Control Treatment for Adolescents With Panic Disorder

NCT00705380

COMPLETED NA

Behavioral Treatments for Acute Stress Disorder In Firefighters

NCT00183508

← Previous Page 4 of 4

Phase Distribution

PhaseTrial count
Phase 1 19
Phase 2 16
Phase 3 4
Phase 4 8

What is open in the Boston University pipeline

23 recruiting of 185 indexed (12% open); 125 completed (68%).

Phase mix: 12 late (III/IV) vs 35 early (I/II) (early-phase heavy).

Top condition: HIV Infections (3 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Boston University: open-pipeline peers nationwide

Peers matched on 185 registered trials and 12% open enrollment, not the therapeutic-area sidebar.

Boston University sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05001,0001,500 10%12%14%16%18% Total trials Recruiting share Boston UniversityNational Human Genome Research Institute (NHGRI)Children's Mercy Hospital Kansas CityArizona State UniversityJohns Hopkins Bloomberg School of Public HealthAstraZenecaNational Heart, Lung, and Blood Institute (NHLBI)Addario Lung Cancer Medical InstituteAmerican University
Boston University sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Boston University sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 185 trials (± recruiting share)

Sponsors near 12% open enrollment (± trial volume)

What to do with this Boston University page

185 registered trials is a research-attention snapshot, not an endorsement of Boston University or any single study.

  • 23 of Boston University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • HIV Infections is the condition Boston University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See HIV Infections trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Boston University pipeline card: 185 registered trials from official public datasets.Report a data error.